Experienced and Result-Driven Pharma Sales and Marketing Professional with Proven Expertise in Oncology: Strategic Go-To-Market Strategy, Dynamic Execution, Innovative New Launches, and P&L Management
The second annual survey shows pharma is making progress, but still has a long way to go to digitally enable the marketing function. Over the years, biopharma companies have gone to great lengths to transform themselves digitally. They’ve onboarded serious technology, made eight-figure investments and hired scores of subject matter experts. However, as counterintuitive as it may seem, those in the marketing and commercial ranks say the industry has yet to make major gains on the digital transformation front. Data from the second annual MM+M/Publicis Health Pharma Marketing Transformation Survey backs up what industry leaders told MM+M. Salil Kallianpur https://lnkd.in/gDF8c2jP
Digital transformation takes time, effort, and perseverance. Patience is key.
Wonderful insights Amaninder. I wonder what are some the key reasons behind this in pharma commercial function. We at DS Tech have been helping a few clients with data and AI in pharma. The adoption is slow but getting there. I sense a lot of energy and enthusiasm around the value of data-AI in the industry in India, but a lot more works needs to be done in terms of org. Culture, awareness, ROI etc. I also think practioners like us must partner closely with the industry in proving the value of data-AI initiative, a close principle on which we at DS technology operate